Enhancing the QUAlity and Transparency Of health Research

Search for reporting guidelines

Use your browser's Back button to return to your search results

Benefit -Risk Assessment of Vaccines. Part II : Proposal Towards Consolidated Standards of Reporting Quantitative Benefit -Risk Models Applied to Vaccines (BRIVAC)

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
Reporting of vaccine quantitative benefit-risk model (qBRm) research.
Full bibliographic reference Arlegui H, Bollaerts K, Bauchau V, Nachbaur G, BĂ©gaud B, Praet N. Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC). Drug Saf. 2020;1-16.
Language English
PubMed ID 32918682
Relevant URLs
(full-text if available)
The full-text of the BRIVAC reporting guideline is available at: https://link.springer.com/article/10.1007%2Fs40264-020-00982-9

The BRIVAC checklist can be accessed at: https://link.springer.com/article/10.1007/s40264-020-00982-9/tables/2

Reporting guideline acronym BRIVAC
Clinical area Infectious diseases, Pharmaceutical medicine, Public health
Applies to the whole report or to individual sections of the report? Whole report
Record last updated on October 2, 2020


Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.